This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (542) Patient-Reported Outcome Measures (PROMs) (275) Clinical Cancer Research (73)

Published on in Vol 11, No 9 (2022): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/36632, first published .
Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study

Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study

Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study

Authors of this article:

Ida Marie Lind Rasmussen1, 2 Author Orcid Image ;   Anne Vest Soerensen1 Author Orcid Image ;   Anne Kirstine Møller1 Author Orcid Image ;   Gitte Fredberg Persson1, 2 Author Orcid Image ;   Jesper Andreas Palshof1 Author Orcid Image ;   Gry Assam Taarnhøj3 Author Orcid Image ;   Helle Pappot2, 3 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Pappot H, Taarnhøj G, Bentsen L, Friis R, Bæksted C, Christiansen M, Holländer-Mieritz C, Møller P, Rasmussen I, Lund-Jacobsen T, Stormoen D, Tolstrup L. Patient-reported outcomes used actively in cancer patients undergoing antineoplastic treatment: A mini-review of the Danish landscape. Computational and Structural Biotechnology Journal 2024;24:23 View